|Articles|May 10, 2018

First NFL Athlete Applies for Cannabis-Based Therapeutic Use Exemption

Mike James, a free agent with the National Football League (NFL) and former running back for the Tampa Bay Buccaneers and the Detroit Lions, is the first NFL athlete to apply for a therapeutic use exemption (TUE) for cannabis. James’s physician, Dr. Sue Sisley, completed the TUE application for medical cannabis on behalf of James back in March 2018. That application was recently denied by the NFL.

According to a press release from the nonprofit organization Doctors for Cannabis Regulation (DFCR) (1), after James suffered a devastating leg injury and surgery he was prescribed opioids to manage his pain. He developed a year-long dependency, which finally led him to seek alternative treatment: cannabis.

The DFCR works with a roster of current and former NFL players to persuade the league to change its regressive cannabis use policy. One of their primary reasons for advocating for this change is the fact that NFL players are four times more likely than the general population to develop an opioid dependency. Even though many states have legalized cannabis use either fully or for medical purposes, the NFL still refuses to give players a viable alternative to opioids.

In an interview with NJ.com (2), James said he was hopeful that he’d be able to keep playing football. "It is a game that I love very dearly,” he said. “I know right now I'm doing something that makes some people uncomfortable, and that I'm going against the establishment to push for a change in the way they look at this medicine. I know there's a greater purpose here for a lot of guys in this league who I consider family members."

References:

  1.  www.DFCR.org
  2. http://www.nj.com/giants/index.ssf/2018/05/mike_james_marijuana_fight_nfl_column_politi.html

Related to this article

2025 Medical Cannabis Roundup
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Image | adobe.stock/Stock Rocket
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
Manipulating Cannabis Genetics: Pulling Levers to Increase  Phytochemical Composition
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
Image | adobe.stock/Maksim Kabakou
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!